Advertisement
UK markets open in 2 hours 51 minutes

  • NIKKEI 225

    38,105.30
    +143.50 (+0.38%)
     

  • HANG SENG

    16,460.09
    +208.25 (+1.28%)
     

  • CRUDE OIL

    82.93
    +0.24 (+0.29%)
     

  • GOLD FUTURES

    2,389.50
    +1.10 (+0.05%)
     

  • DOW

    37,753.31
    -45.66 (-0.12%)
     

  • Bitcoin GBP

    49,748.02
    -1,504.16 (-2.93%)
     

  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

  • NASDAQ Composite

    15,683.37
    -181.88 (-1.15%)
     

  • UK FTSE All Share

    4,273.02
    +12.61 (+0.30%)
     
Money:

5 ways to get help with childcare costs

Childcare is eye-wateringly expensive, here are some ways to save money

AstraZeneca CEO Soriot says to work with new chairman for many years

Reuters
·1-min read
FILE PHOTO: Pascal Soriot, chief executive of AstraZeneca, attends an interview with Reuters in Shanghai

FRANKFURT (Reuters) - Long-serving AstraZeneca boss Pascal Soriot said on Friday he expects to work with the new chairman-designate of the London-listed drugmaker, who will take over in 2023, for many years to come, suggesting he is not ready to retire.

The company said on Friday that Michel Demare will take over from outgoing Chairman Leif Johansson, who, like Soriot, has been in his leadership position for about a decade.

"Michel and I will be working together and forming an excellent team for the many years to come," Soriot said on an analyst call after the company released its quarterly results.

(Reporting by Ludwig Burger and Natalie Grover; editing by Jason Neely)